AGP Picks
View all

Entertainment Wire Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.

Press releases published on May 21, 2026

MadHat Media Formalizes Equity Engineering Partnership with SapientSwift Solutions to Accelerate Global DDARP Deployment
MadHat Media Engages Ricci Capital Partners to Lead Series A Capital Formation
Ricci Capital Partners Leadership Joins MadHat Media Board of Advisors
LiveData Launches LiveData Insights AI Advisor to Give Every Hospital Leader Real Time Answers from the Operating Room
Descendant of Boxing Legends Unearths Lost American Epic in THE ST. PAUL PHANTOM: The Gibbons Brothers’ Fight for Glory, Volume I
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
Lili Latin Dance Celebrates Three Years of Community, Culture and Connection in Boston
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
Scientists map which genes are active in a developing seed to build hardier crops
Bierman Autism Centers Tests New ABA Curriculum Built to Help Children Make Faster Progress
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy
Rgenta Therapeutics Presents Positive Preliminary Data from Ongoing Phase 1a/b Clinical Trial of RGT-61159 in Patients with Adenoid Cystic Carcinoma and Colorectal Cancer at the 2026 ASCO Meeting
Kadant Authorizes Share Repurchase
Kadant Declares Cash Dividend
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Entertainment Wire Massachusetts

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.